Clinical and economic analysis of empagliflozin therapy in patients with heart failure across the ejection fraction range

Clinical and economic analysis of empagliflozin therapy in patients with heart failure across the ejection fraction range

Aim. To evaluate the cost-effectiveness of empagliflozin therapy in patients with heart failure (HF) across the ejection fraction (EF) range in the Russian Fe­­deration.Material and methods. An analysis of the cost of HF management was carried out and an analytical decision-making model was built in...

Full description

Bibliographic Details
Main Authors: S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Lutova, E. A. Popova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-07-01
Series:Российский кардиологический журнал
Subjects:
heart failure
empagliflozin
budget impact analysis
clinical economic analysis
cost of illness
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5475

Internet

https://russjcardiol.elpub.ru/jour/article/view/5475

Similar Items